• Beauty Farm flagged a stronger first half, projecting revenue of at least RMB 1.88 billion, up at least 28% year over year.
• Adjusted net profit seen at least RMB 260 million, up at least 36%; net profit forecast at least RMB 235 million, up at least 37%.
• Outlook supported by acquisition-led expansion, with Siyanli results consolidated from January 2026 following its 2025 purchase.
• Organic growth also contributed, with same-store revenue rising at directly operated stores; CellCare brand upgrade lifted aesthetic medical services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beauty Farm Medical & Health Industry Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12248979), on July 19, 2026, and is solely responsible for the information contained therein.